Kovack Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,844
| Closed | -$391K | – | 630 |
|
|
2024
Q3 | $391K | Buy |
5,844
+3,946
| +208% | +$264K | 0.04% | 366 |
|
|
2024
Q2 | $225K | Sell |
1,898
-833
| -31% | -$98.9K | 0.02% | 497 |
|
|
2024
Q1 | $291K | Buy |
2,731
+23
| +0.8% | +$2.45K | 0.04% | 358 |
|
|
2023
Q4 | $269K | Sell |
2,708
-662
| -20% | -$65.8K | 0.03% | 445 |
|
|
2023
Q3 | $348K | Sell |
3,370
-27
| -0.8% | -$2.79K | 0.05% | 345 |
|
|
2023
Q2 | $413K | Sell |
3,397
-1,522
| -31% | -$185K | 0.05% | 336 |
|
|
2023
Q1 | $755K | Buy |
4,919
+102
| +2% | +$15.7K | 0.1% | 200 |
|
|
2022
Q4 | $865K | Sell |
4,817
-648
| -12% | -$116K | 0.13% | 177 |
|
|
2022
Q3 | $646K | Buy |
5,465
+70
| +1% | +$8.27K | 0.09% | 232 |
|
|
2022
Q2 | $771K | Sell |
5,395
-705
| -12% | -$101K | 0.1% | 210 |
|
|
2022
Q1 | $1.05M | Sell |
6,100
-739
| -11% | -$127K | 0.11% | 203 |
|
|
2021
Q4 | $1.74M | Sell |
6,839
-3,322
| -33% | -$844K | 0.17% | 135 |
|
|
2021
Q3 | $3.91M | Buy |
10,161
+1,914
| +23% | +$737K | 0.43% | 39 |
|
|
2021
Q2 | $1.94M | Sell |
8,247
-113
| -1% | -$26.6K | 0.22% | 123 |
|
|
2021
Q1 | $1.1M | Sell |
8,360
-185
| -2% | -$24.2K | 0.14% | 168 |
|
|
2020
Q4 | $893K | Sell |
8,545
-817
| -9% | -$85.4K | 0.13% | 180 |
|
|
2020
Q3 | $662K | Buy |
9,362
+5,691
| +155% | +$402K | 0.12% | 188 |
|
|
2020
Q2 | $236K | Buy |
+3,671
| New | +$236K | 0.05% | 362 |
|